In a CARACAL meeting, the European Commission has introduced the latest update of the ‘Rolling List of (groups of) substances for restriction’, which is part of the Restrictions Roadmap. HEAL has provided feedback to the updated rolling list and note concerns on the repeated delays in the implementation of restrictions of groups of substances that have been included in the Roadmap for several years.
The European Commission is currently evaluating the Cosmetic Products Regulation. HEAL has submitted our input to the public consultation and highlight for example the importance of the regulation for the protection of EU citizens from substances that can affect hormone-driven processes. This evaluation initiative runs in parallel to the discussions on the Cosmetic Products Regulation as part of the Sixth Omnibus proposal from the European Commission.
Below are HEAL’s recommendations for the Cosmetic Products Regulation in summarised five main points:
- Ensuring health protection from endocrine disruptors
- Addressing mixture effects from the co-exposure to chemicals
- Taking precautionary measures for substances without conclusive evidence on safety
- Mandating regular reviews of approvals for preservatives, colorants and UV filters
- Aligning the CPR with other EU chemical legislations
Access the full comments on the evaluation of the Cosmetics Products Regulation.
HEAL’s input to the previous Call for Evidence on the evaluation of the Cosmetic Products Regulation can be found here.
HEAL’s analysis of key concerns of the omnibus proposals for the use of carcinogens, mutagens and reprotoxic substances in cosmetic products is available here.
